News and Comments

ARCA BIOPHARMA: A GENETICALLY TARGETED DRUG FOR ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS

  Thursday, January 09, 2014

A Colorado-based biopharmaceutical company, ARCA Biopharma (ABIO) has a genetically-targeted drug, GencaroTM (bucindolol hydrochloride), for Atrial fibrillation (AF) in patients with heart failure (HF). The drug offers a personalized medicine approach for the treatment of AF in HF, treating only individuals with certain genetic characteristics. This approach enables the selection of individuals who would most probably respond to the drug through excluding the expected non-responders, thus reducing statistically failed trial outcome, in addition to decreasing clinical trial and healthcare costs.    More...


Recent Postings


Archive


Tags

C4 Therapeutics GlaxoSmithKline (GSK) Biogen Idec (BIIB) MODERNA NOVOCURE (NVCR) Mirati Therapeutics (MRTX) Trastuzumab-DM1 Array Pharmaceuticals (ARRY) JUNO (JUNO) Xoma (XOMA) Abbott Laboratories (ABT) Alnylam (ALNY) Agenus (AGEN) Herceptin Aimmune Therapeutics (AIMT) ADVENTRIX (ANX) Valeant Pharmaceuticals International (VRX) Sanofi (SNY) Advaxis (ADXS) Adaptimmune (ADAP) Spike Therapeutics (ONCE) JOUNCE THERAPEUTICS (JNCE) Ariad (ARIA) Sarepta (SRPT) NEKTAR (NKTR)) Exelixis (EXEL) Bellicum (BLCM) Jazz Pharmaceuticals (JAZZ) Genentech Theravance Bio Pharma (TBPH) KERYX (KERX) Roche (RHHBY) Galena (GALE) Editas (EDIT) Revlimid (lenolidamide) RenenxBio (RGNX) Multiple Myeloma Prolor Biotech (PBTH) AGOS (ARGS) Cytokinetics (CYTK) Merck (MRK) AERIE PHARMACEUTICALS Roche (ROCHE) Ridaforolimus PORTOLA (PTLA) Bristol-Myers Squibb (BMY) ARGOS (ARGS) CompuGen (CGEN) Intermune (ITMN) Intercept (ICPT) ISIS (ISIS) ARCA (ABIO) Inovio (INO) Global Cell Therapeutics (GBT) Zerenex Dynavax (DVAX) Ziofpharm (ZIOP) Micromet (MITI) Onyx (ONXX) NANTKWEST (NK) Anacor (ANAC) SERES THERAPEUTICS (MCRB) Pluristem (PSTI) Vertex (VRTX) Auspex (ASPX) ZALTRAP™ Akebia Therapeutics (AKAB) REGULUS (RGLS) OncoCyte (OCX) GlycoMimetics (GLYN) Epizyme (EPZM) Alder Biopharmaceuticals (ALDR) Gilead (GILD) Agenus (AGEN Sangamo (SGMO) Regeneron (REGN) Seattle Genetics (SGEN) TOKAI (TKAOI) CEMPRA (CEMP) Incyte (INCY) SUNESIS PHARMACEUTICALS (SNSS) BIOMARIN (BMRN) Human Genome Sciences (HGSI) Intrexon (XON) Biocryst (BCRX) HALOZYME (HALO) Anadys (ANDS) LEXICON (LXRX) Telaprevir Vitae Pharmaceuticals (VTAE) ImmunoGen (IMGN) Velcade (bortezomib) KITE (KITE) CRISPR Therapeutics (CRSP) galapagos (GLPG) Ocular Therapeutix (OCUL) Benlysta (belimumab) Ionis (IONS) PTC Therapeutics (PTCT) Sanofi (SNA) VANDA (VNDA) Rapamune Human Longevity (HLI) Tysabri SYNTA (SNTA) Amgen (AMGN) Idenix (IDIX) GUARDIAN HEALTH Illumina (ILMN) Sanofi-Aventis (SAN) ABBVIE (ABBV) Theravance (THRX) ACADIA (ACAD) OSI (OSIP) IDERA (IDRA) AstraZeneca (AZN) Dendreon (DNDN) Prosensa (RNA) NEUROCRINE (NBIX) Sequenom (SQNM) INNOVIVA (INVA) Endometrial Cancer Elan (ELN)